.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Updates in Immunotherapy for Advanced Thoracic Malignancies

EP. 1: Frontline Treatment in Non–Small Cell Lung Cancer

October 26th 2020

EP. 2: Treatment Efficacy in Non–Small Cell Lung Cancer

October 26th 2020

EP. 3: Treatment Options in PD-L1 Positive Non–Small Cell Lung Cancer

October 26th 2020

EP. 4: Chemotherapy and Immunotherapy in Non–Small Cell Lung Cancer

October 26th 2020

EP. 5: Understanding Immune Response in Non–Small Cell Lung Cancer

October 26th 2020

EP. 6: Treatment for PD-L1 High/Low/Negative Non–Small Cell Lung Cancer

October 26th 2020

EP. 7: Recent Advances in Small-Cell Lung Cancer

October 26th 2020

EP. 8: Treatment Options in Small–Cell Lung Cancer

October 26th 2020

EP. 9: Treatment for Progressive Small-Cell Lung Cancer

October 26th 2020

EP. 10: Trials in Limited-Stage Small-Cell Lung Cancer

October 26th 2020

EP. 11: Fundamentals of Mesothelioma

October 26th 2020

EP. 12: Mesothelioma: A Look at DREAM3R and PrECOG Trial

October 26th 2020

EP. 13: The Future of Lung Cancer Treatment

October 26th 2020